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Abstract
Gonadotropin-primed immature rats (GPIR) constitute a widely used model for the study of
ovulation. Although the equivalence between the ovulatory process in immature and adult rats is
generally assumed, the morphological and functional characteristics of ovulation in immature rats
have been scarcely considered. We describe herein the morphological aspects of the ovulatory
process in GPIR and their response to classical ovulation inhibitors, such as the inhibitor of
prostaglandin (PG) synthesis indomethacin (INDO) and a progesterone (P) receptor (PR)
antagonist (RU486). Immature Wistar rats were primed with equine chorionic gonadotropin (eCG)
at 21, 23 or 25 days of age, injected with human chorionic gonadotropin (hCG) 48 h later, and
sacrificed 16 h after hCG treatment, to assess follicle rupture and ovulation. Surprisingly, GPIR
showed age-related ovulatory defects close similar to those in adult rats lacking P and PG actions.
Rats primed with eCG at 21 or 23 days of age showed abnormally ruptured corpora lutea in which
the cumulus-oocyte complex (COC) was trapped or had been released to the ovarian interstitum,
invading the ovarian stroma and blood and lymphatic vessels. Supplementation of immature rats
with exogenous P and/or PG of the E series did not significantly inhibit abnormal follicle rupture.
Otherwise, ovulatory defects were practically absent in rats primed with eCG at 25 days of age.
GPIR treated with INDO showed the same ovulatory alterations than vehicle-treated ones,
although affecting to a higher proportion of follicles. Blocking P actions with RU486 increased the
number of COC trapped inside corpora lutea and decreased ovulation. The presence of ovulatory
defects in GPIR, suggests that the capacity of the immature ovary to undergo the coordinate
changes leading to effective ovulation is not fully established in Wistar rats primed with eCG before
25 days of age.
Introduction
Ovulation, the release of mature oocytes from the ovary,
requires proteolytic degradation of the follicle wall, as
well as the overlying ovarian tissues. This happens
through the expression of a series of critical genes, trig-
gered in a precise temporal and spatial pattern by the pre-
ovulatory LH surge [1,2]. It is worthy to note that, for
successful ovulation, follicle rupture has to occur just at
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the site of the follicle wall facing the ovarian surface, thus
allowing release of the cumulus-oocyte complex (COC) to
the periovarian space, while preventing proteolytic dam-
age of the perifollicular tissues at the basolateral follicle
sides. A large amount of information on the ovulatory
process was accumulated during the last century
(reviewed in [1-5]), and the involvement of crucial genes
such as those encoding cyclooxygenase-2 (COX-2), and
progesterone receptor (PR) has been clearly established.
However, the mechanisms underlying the spatial target-
ing of the follicle rupture remain poorly understood.
Although mechanical factors are likely involved in stigma
formation and rupture [6], the mechanisms responsible
for the specific location of proteolytic breakdown of the
theca layers and perifollicular connective tissue at the apex
of the follicle are not known. In recent studies [7-9] we
have proposed that both prostaglandins (PG) and proges-
terone (P), classically recognized as essential ovulatory
factors [1,2], play complementary roles in the spatial tar-
geting of follicle rupture. This was supported by detailed
morphological studies in cycling rats treated with
indomethacin (INDO), a strong inhibitor of PG synthesis,
and RU486 (a PR antagonist), showing antiovulatory
effects [1,2,10-12].
Gonadotropin-primed immature rats (GPIR) constitute a
useful model for the study of ovulation. The administra-
tion of a single dose of equine chorionic gonadotropin
(eCG) to immature animals induces the growth of abun-
dant follicles, that reach preovulatory size in two days.
Ovulation is then triggered by a single dose of human
chorionic gonadotropin (hCG), thus providing a large
number of synchronized ovulatory follicles [13-25]. An
additional advantage of this model is the absence of
regressing corpora lutea of previous cycles. This is relevant
because structural luteolysis, that is temporally coincident
with ovulation in cycling rats, also involves tissue remod-
eling and proteolytic degradation of the extracellular
matrix [5]. For these reasons, GPIR (ranging from 21 to 28
days of age, at the time of eCG treatment [13-25]), have
been widely used in studies focused on the ovulatory
process, and a large amount of the information in this
topic is derived from studies in immature rats. However,
it should be kept in mind that GPIR constitute a non-
physiological model and the possible immaturity of the
pathways leading to ovulation cannot be ruled out.
In order to examine further the role of PG and P in follicle
rupture and ovulation, we performed detailed morpho-
logical analysis of the ovulatory process in inmature rats
primed with gonadotropins at different ages. Surprisingly,
these animals showed age-related alterations of the folli-
cle rupture similar to those of adult rats lacking PG and P
actions. We report herein the morphological alterations of
follicle rupture and ovulation in GPIR and the effects of
treatment with P and/or PG of the E series, as well as the
response of GPIR to PG synthesis inhibition with INDO
and to a PR antagonist (RU486), whose inhibitory effects
in ovulation are clearly established [1,2,8,13,14].
Materials and methods
Animals and drugs
Wistar female rats bred in the vivarium of the University
of Cordoba were used. The day the litters were born was
considered as day 0. Litter size was adjusted to 8 pups. The
animals were maintained under controlled conditions of
light (14L:10D; lights on 0500-1900) and temperature
(22°C). The animals had free access to pelleted food and
tap water. Experimental procedures were approved by the
Cordoba University Ethical Committee for animal experi-
mentation and were conducted in accordance with the
European Union guidelines for care and use of experi-
mental animals. Indomethacin (INDO), Progesterone
(P), equine chorionic gonadotropin (eCG), human chor-
ionic gonadotropin (hCG) and prostaglandins were pur-
chased from Sigma.(St Louis, MO). The progesterone
antagonist RU486 was obtained from Exlegin (Paris,
France).
Gonadotropin-priming at different ages
Wistar immature rats were injected sc with 10 IU of eCG
at 1700 h at 21, 23 or 25 days of age, and 48 h later were
injected sc with 10 IU of hCG, a frequently used schedule
[23,26,27]. Body weights were in the recommended range
[23,26] (46.0 ± 0.34, 57.0 ± 1.30 and 61.8 ± 1.4 g, mean
± SEM for n = 5). The animals (5 per group) were sacri-
ficed at 0900 h on the day following hCG injection (i.e. at
24, 26 and 28 days of age). The ovaries, including the
ovarian bursa, oviducts and periovarian fat pad, were
fixed in Bouin-Hollande's fluid for 24 h and processed for
paraffin embedding.
Gonadotropin-primed rats treated with prostaglandins 
and/or progesterone
Immature rats were primed with eCG at 21 days of age
and with hCG 48 h later as described above. In addition,
these animals were injected with 100 µg of PGE1 or PGE2,
1 mg of P or 1 mg of P plus 100 µg of PG E1 or PGE2 or
vehicles (70% ethanol in saline) at 1730 h (30 min after
hCG treatment). These dosages were effective, in the same
body weight basis, in previous studies in adult rats [9].
The animals (5 per group) were killed at 0900 h on the
day after hCG treatment (i.e. at 24 days of age) and the
ovaries were processed as described above.
Gonadotropin.primed rats treated with indomethacin or 
RU486
Immature rats were primed with eCG at 23 days of age
and with hCG 48 h later as described in previous experi-
ments. Indomethacin-treated rats received a sc injection ofReproductive Biology and Endocrinology 2004, 2:63 http://www.rbej.com/content/2/1/63
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0.5 mg of INDO or vehicle (olive oil) at 1200 h at 25 days
of age. RU486-treated rats were injected sc with 0.5 mg of
RU486 or vehicle (olive oil) at 0900 h at 24 and 25 days
of age.The animals (5 per group) were killed at 0900 h on
the day following hCG injection (i.e. at 26 days of age)
and the ovaries were processed as described above.
Histological analysis of follicle rupture and ovulation
The right ovaries were serially sectioned (6 µm) and
stained with hematoxylin and eosin. All sections were
examined under the microscope. The total number of
cumulus-oocyte complexes (COCs) per ovary were
counted. The number of COCs trapped inside the corpus
luteum, released to the ovarian interstitium, retained in
the bursal cavity or found in the oviducts, was recorded.
COCs released to the ovarian interstitium were clearly rec-
ognizable by the presence of the oocyte in metaphase II
and the first polar body, dispersed cumulus and follicular
fluid. The total number of COCs per ovary matches the
total number of corpora lutea (unruptured or not). In
addition to absolute values, the number of COCs in each
location was expressed as the percentage with respect to
the total number of COCs (or corpora lutea) per ovary, to
assess ovulatory efficiency, avoiding variability in the total
numbers of corpora lutea among the different groups.
Unruptured follicles measuring less than 575 µm in diam-
eter, showing signs of atresia, such as irregularities of the
granulosa cell layer, presence of apoptotic granulosa cells,
as well as lack of dispersion of the cumulus or resumption
of meiosis, were not considered.
Statistical analysis was performed by ANOVA followed by
the Student-Newman-Keuls method for multiple compar-
ison among means. Significance was considered at the
0.05 level.
Results
Ovulatory process in immature rats primed at different 
ages
Absolute numbers of COCs, that match the numbers of
corpora lutea per ovary, are presented in Table 1, whereas
relative data (the proportion of COCs found in each spe-
cific location) are shown in Fig. 6. On the day following
hCG treatment, the total number of COCs per ovary was
equivalent for the different age-groups (Table 1). Imma-
ture rats primed with eCG at 21 or 23 days of age showed
frequent ovulatory defects (see Figs 1,2,3,4,5 for repre-
sentative micrographs and Fig. 6. for quantitative data).
The COC was trapped in about 60% and 40% of the lutei-
nized follicles in rats primed with eCG at 21 and 23 days
of age respectively (Figs. 1A, 2, 6). However, many lutein-
ized follicles containing the COC showed rupture of the
theca layers and release of follicular fluid to the ovarian
interstitium (Fig. 1A). Furthermore, 6–10% of the COCs
were released to the ovarian interstitum (Figs. 1B, 2, 3, 6).
In these cases, degradation of the ovarian stroma with
invasion of the blood and lymphatic vessels and forma-
tion of emboli containing the COC and follicular fluid
(Figs 1C,1D,1E,1F, 2, 3) were observed. In some animals,
massive embolism of the ovarian vein at the ovarian hilus
with follicular fluid and COCs (Fig. 3) caused ovarian
hyperemia and vascular congestion. In addition, proteo-
lytic degradation of the ovarian bursa by follicular fluid
and granulosa cells, with invasion of the periovarian fat
pad (Fig. 1G,1H) and even release of the COC to the peri-
toneal cavity (Fig. 4), was also observed. A characteristic
feature of some corpora lutea ruptured at the apex, was the
presence of an unruptured ovarian surface epithelium,
and the COC was trapped in lacunae of follicular fluid
and blood in the tunica albuginea (Fig. 5). Variable num-
bers of COCs (from 0 to 25%) were located in the bursal
cavity (Fig. 6). From 33% to 60% of COCs were found in
the oviducts, in rats primed with eCG at 21 and 23 days of
age respectively. Otherwise, in immature rats primed with
eCG at 25 days of age, the vast majority of COCs were
found in the oviducts and abnormally ruptured corpora
lutea (with trapped COC) were only occasionally found.
Table 1: Number of COCs per ovary in control rats primed with eCG at different ages.
Age (days) at eCG 
treatment
Total COCs COCs located in
Corpus luteum Interstitium Ovarian Bursa Oviduct
21 42.5 ± 8.72 22.5 ± 4.32 3.17 ± 1.47 0.67 ± 0.42 16.2 ± 6.93
23 58.4 ± 4.74 18.8 ± 0.70 3.20 ± 1.74 2.40 ± 0.51 34.0 ± 6.54
25 38.6 ± 3.76 0.6 ± 0.60a,b -- -- 37.4 ± 3.20
Values are the mean ± SEM for n = 5. ANOVA and Student-Newman-Keuls multiple range test. a p < 0.05 vs 21 days. b p < 0.05 vs 23 daysReproductive Biology and Endocrinology 2004, 2:63 http://www.rbej.com/content/2/1/63
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Representative micrographs from the ovary of immature rats primed with eCG at 21 (A-D, G, H) or 23 (E, F) days of age,  stained with hematoxylin and eosin Figure 1
Representative micrographs from the ovary of immature rats primed with eCG at 21 (A-D, G, H) or 23 (E, F) days of age, 
stained with hematoxylin and eosin. A, luteinized follicle showing trapped COC and release of follicular fluid (FF) to the ovarian 
interstitium. The rupture of the theca layers are indicated by arrows. B, COC released to the ovarian interstitium, in a lacunae 
of follicular fluid (FF). Clusters of granulosa cells are indicated by open arrows. C, D, COCs in the lymphatic (A) or blood (D) 
vessels at the ovarian hilus (OH). E, F, COC inside a blood vessel located in the periovarian fat pad (PFP) near the ovarian hilus 
(OH). The framed area is shown at higher magnification in F showing rupture of the blood vessel and escape of red blood cells 
(arrows). G, H, Non-consecutive serial sections showing a COC released to the bursal cavity (BC), adhered to the ovarian 
bursa. Degradation of the ovarian bursa by follicular fluid and granulosa cells (open arrows) and invasion (arrows) of the perio-
varian fat pad (PFP) can be observed.
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Effects of P and/or PGE treatment
The total number of COCs per ovary was equivalent in
rats primed with eCG at 21 days of age and treated with
vehicles, P, PGE1, PGE2, P plus PGE1 or P plus PGE2
(Table 2). Neither P, PG or combined P plus PG treat-
ment, prevented ovulatory defects and these animals
showed the same morphological alterations as gonado-
tropin and vehicle-treated rats. However, degradation of
the interstitial tissue and embolism of blood vessels with
follicular fluid and granulosa cells were very scarce in
prostaglandin-treated animals. Although the number of
effectively ovulated oocytes were apparently increased in
prostaglandin-treated rats, differences were not large
enough to be statistically significant (Fig. 7).
Effects of INDO or RU486 treatments
The total number of COCs per ovary was equivalent in
rats treated with vehicle, INDO or RU486 (Table 3).
Immature rats treated with INDO during the preovulatory
period showed the same morphological alterations of the
Micrograph of the ovary of a rat primed with eCG at 21 days of age, stained with hematoxylin and eosin Figure 2
Micrograph of the ovary of a rat primed with eCG at 21 days of age, stained with hematoxylin and eosin. Several COCs 
trapped inside corpora lutea, showing dispersion of the cumulus, and interstitial COCs inside a blood vessel.
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Non-consecutive serial sections of the ovary of a rat primed with eCG at 21 days of age and stained with hematoxylin and  eosin Figure 3
Non-consecutive serial sections of the ovary of a rat primed with eCG at 21 days of age and stained with hematoxylin and 
eosin. The ovarian vein is embolized with folicular fluid and two COCs (in A and B). A COC released to the ovarian hilus can 
be also observed in A. The ovarian surface is indicated by empty arrows in the inset.
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ovulatory process as gonadotropin and vehicle-treated
rats, although a higher proportion of follicles were
affected (Fig. 8). A significantly (p < 0.05) higher number
of COCs were released to the ovarian interstitium,
whereas the number of COCs found in the oviducts was
significantly (p < 0.05) decreased. Rats treated with
RU486 showed increased numbers of COCs retained
inside the follicle (Fig. 8), whereas the number of COCs
released to the interstitium or effectively ovulated were
significantly decreased. Most of the luteinized follicles in
which the COC was trapped, did not show evident rup-
ture of the theca layers. The numbers of COC trapped in
the bursal cavity was significantly increased (Table 3 and
Fig. 8).
Discussion
Gonadotropin-primed immature rats (GPIR) is a popular
model for the study of ovulation. In this model, eCG stim-
ulates the growth of a large cohort of follicles, that reach
preovulatory size in about 48 h and are then induced to
ovulate by hCG [1,2,28]. Early data indicate that the ovu-
lation rate in immature rats was age-dependent, and that
the number of ova found in the oviducts increases,
although not linearly, with age [29,30]. However, these
early studies do not provide information on the number
of ova that were not effectively ovulated, and the marked
variability in the rate of ovulation at different ages could
be due to differences in the number of recruited growing
follicles, in the responsiveness of preovulatory follicles to
the ovulatory stimulus or both. In the present study, we
evaluated the ovulatory process in immature rats primed
with gonadotropins during the 21–25 day-old period,
commonly used in studies focused on ovulation
[13,17,18,20-23,25,26]. In agreement with previous data
[29,30], the proportion of COCs found in the oviducts
(i.e. effectively ovulated) increases in parallel to age.
Micrographs from non-consecutive serial sections from the ovary of an immature rat primed with eCG at 21 days of age Figure 4
Micrographs from non-consecutive serial sections from the ovary of an immature rat primed with eCG at 21 days of age. The 
ovarian bursa (OB) has been degraded (A) allowing release of the COC to the peritoneal cavity (B) Clusters of granulosa cells 
(arrows) can be observed free or attached to the ovarian bursa. Hematoxylin and eosin.
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Representative micrographs from the ovary of immature rats primed with eCG at 21 (A) or 23 (B) days of age, showing lutein- ized follicles ruptured at the apex Figure 5
Representative micrographs from the ovary of immature rats primed with eCG at 21 (A) or 23 (B) days of age, showing lutein-
ized follicles ruptured at the apex. The ovarian surface epithelium (OSE, arrows in A and B), and its basement membrane (arrow-
heads in B) remain intact, whereas the underlying ovarian tissue has been degraded (asterisk in A). The COC is retained under 
the ovarian surface. OB, ovarian bursa. Hematoxylin and eosin.
B
A
OB
Bursal
cavity
COC
OSE
*
OSE
COC
150 Pm
50 PmReproductive Biology and Endocrinology 2004, 2:63 http://www.rbej.com/content/2/1/63
Page 9 of 12
(page number not for citation purposes)
Detailed morphological evaluation indicated that ovula-
tion was unsuccessful in 30–60% of preovulatory follicles
in rats primed with eCG before 25 days of age. The nearly
normal ovulatory process in immature rats primed with
eCG at 25 days of age indicates that ovulatory defects were
not due to gonadotropin treatment itself, but to ovarian
immaturity at earlier ages. The ovulation failure described
herein (in rats primed with eCG at 21 or 23 days of age)
was not due to decreased recruitment of growing follicles,
as indicated by the equivalent numbers of follicles that
reach preovulatory size at all ages tested. The data of this
study strongly suggest that the relative ovulatory incompe-
tence of young immature rats was due to a defective capac-
ity of preovulatory follicles to undergo the coordinate
Percentage of cumulus-oocyte complexes (COCs) trapped  inside the corpus luteum, released to the interstitium,  located in the bursal cavity, or in the oviducts, in immature  rats primed with eCG at 21, 23 or 25 days of age and ovulat- ing at 24, 26 or 28 days of age respectively Figure 6
Percentage of cumulus-oocyte complexes (COCs) trapped 
inside the corpus luteum, released to the interstitium, 
located in the bursal cavity, or in the oviducts, in immature 
rats primed with eCG at 21, 23 or 25 days of age and ovulat-
ing at 24, 26 or 28 days of age respectively. See Table 1 for 
absolute counts. Different superscripts mean significant (p < 
0.05) differences.
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Percentage of cumulus-oocyte complexes (COCs) trapped 
inside the corpus luteum, released to the interstitium, 
located in the bursal cavity, or in the oviducts, in rats primed 
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ences were found.
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network of interactions that leads, in reponse to hCG, to
COC release to the periovarian space.
Defective ovulation in GPIR was related to abnormal fol-
licle rupture. Whereas some LH-driven morphological
changes in preovulatory follicles, such as cumulus expan-
sion, resumption of the meiotic process and initial lutein-
ization were present and showed normal features in GPIR,
aberrant follicle ruptures were frequently observed. This
was indicated by the presence of COCs released to the
ovarian interstitium, and of corpora lutea showing rup-
ture of the theca layers at any site of the follicle wall with
release of follicular fluid to the ovarian stroma. The pres-
ence of follicle ruptures at the basolateral follicle sides
suggests that the mechanisms underlying the spatial tar-
geting of follicle rupture at the apex are not fully estab-
lished in immature rats primed with eCG before 25 days
of age. Almost identical ovulatory defects have been
previously reported in INDO-treated adult cycling rats
that also show abnormally ruptured follicles and proteo-
lytic degradation of perifollicular tissues [7-9]. Further-
more, INDO-treated GPIR in the present study showed
similar morphological alterations of the ovulatory process
as vehicle-treated GPIR, even though the drug increased
the number of affected follicles. The similarity of the ovu-
latory alterations found in GPIR and INDO-treated adult
rats raises the question of whether the COX-2-prostaglan-
din pathway is fully established or not in GPIR. In this
context, treatment of GPIR with PG of the E series was car-
ried out in order to analyse whether ovulatory defects in
GPIR were due to defective PG synthesis. Treatment with
prostaglandin E resulted in a decrease in the invasion of
the ovarian stroma and blood vessels by follicular fluid
and granulosa cells, but ovulation was not improved sig-
nificantly. In contrast, supplementation with exogenous
PG of the E series inhibits abnormal follilce rupture and
restores ovulation in INDO-treated adult rats [2,8,31].
This suggests that the possible immaturity of the COX-2-
prostaglandin pathway in GPIR would be beyond prostag-
landin synthesis, in agreement with previous studies
reporting normal PG generation in GPIR in response to
hCG treatment [28]. Otherwise, recent studies in COX-2
defective mice [32] indicate that the COX-2-PG pathway is
not fully established in immature rodents.
It has been clearly established that activation of PR plays
a crucial role in ovulation [10,11,33-37]. Accordingly,
adult cycling rats treated with PR antagonists [11] or
inhibitors of the P synthesis [34] during the preovulatory
period showed almost complete inhibition of follicular
rupture [9,11,34]. Noteworthy, the response of GPIR to
PR blockage (showing incomplete inhibition of follicle
rupture) was similar to that of adult rats lacking both P
and PG actions. In this sense, combined treatment of
Table 2: Number of COCs per ovary in rats primed with eCG at 21 days of ages.
Treatment Total COCs COCs located in
Corpus luteum Interstitium Ovarian Bursa Oviduct
Vehicles 35.4 ± 3.52 17.2 ± 1.47 2.6 ± 0.85 0.6 ± 0.24 15.0 ± 2.72
PGE1 33.2 ± 4.20 11.0 ± 2.42 2.3 ± 1.02 1.2 ± 0.58 19.0 ± 3.40
PGE2 33.2 ± 1.62 10.2 ± 2.80 0.6 ± 0.39 3.6 ± 2.59 18.8 ± 3.38
P4 45.6 ± 7.77 17.2 ± 2.97 3.4 ± 1.06 5.8 ± 3.10 19.2 ± 5.45
P4 + PGE1 34.6 ± 5.17 14.6 ± 3.37 0.6 ± 0.39 0.8 ± 0.37 18.6 ± 2.82
P4 + PGE2 35.2 ± 6.85 15.6 ± 3.10 0.6 ± 0.39 5.7 ± 2.85 14.2 ± 1.63
Values are the mean ± SEM for n= 5.
Table 3: Number of COCs per ovary in rats primed with eCG at 23 days of ages.
Treatment Total COCs COCs located in
Corpus luteum Interstitium Ovarian Bursa Oviduct
Vehicle 39.6 ± 1.60 12.8 ± 1.0 2.6 ± 1.73 1.0 ± 0.62 23.2 ± 1.53
INDO 34.4 ± 3.76 19.2 ± 2.55 10.0 ± 1.35a 0.4 ± 0.39 5.0 ± 0.05a
RU486 41.8 ± 3.86 22.8 ± 4.80 0.6 ± 0.39b 3.2 ± 0.57a,b 15.2 ± 3.10a,b
Values are the mean ± SEM for n = 5. ANOVA and Student-Newman-Keuls multiple range test. a p < 0.05 vs vehicle, b p < 0.05 vs INDO.Reproductive Biology and Endocrinology 2004, 2:63 http://www.rbej.com/content/2/1/63
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adult rats with RU486 and INDO resulted in follicle rup-
ture in about 25% of preovulatory follicles [9]. Further-
more, some morphological features of the ovulatory
process in GPIR, such as the persistence of the ovarian sur-
face epithelium in spite of the degradation of the underly-
ing tissues, was also a characteristic feature of adult rats
treated with both INDO and RU486 [9]. However, exoge-
nous P supplementation did not restore ovulation in
GPIR, that suggest a defective response of preovulatory
follicles to the ovulatory LH-dependent P surge. RU486-
treated GPIR showed a significant increase in the number
of COCs retained into the bursal cavity. Alterations in the
transport of COCs to the oviduct has been previously
described in adult rats treated with a PR antagonist [11],
although the existence of a role for P in the COC transport
to the oviduct cannot be ascertained from the present
data.
The end-point of the complex interaction network leading
to follicle rupture and COC release, is the expression/acti-
vation of proteolytic enzymes, reponsible for extracellular
matrix breakdown [24,38,39]. Proteolytic activity has to
be closely modulated by protease inhibitors to prevent
damage to perifollicular tissues. However, the characteri-
zation and regulation of ovarian proteolytic inhibitors has
not been completely elucidated. The presence in GPIR of
degradation of the ovarian stroma, invasion of blood and
lymphatic vessels in abnormally ruptured follicles,
strongly suggest that defective ovulation in GPIR was not
due to decreased proteolytic activity but due to untargeted
proteolysis. This was particularly suggested by the degra-
dation of the ovarian bursa and invasion of the periovar-
ian fat pad by cumulus cells and follicular fluid released at
the follicle apex (see Figs. 1G,1H, 3 and 4), permitting, in
some cases, escape of the COC to the peritoneal cavity. In
this sense, the use of very young immature rats to charac-
terize proteolytic activity regulation during ovulation
could provide conflicting data. In this study, we used Wis-
tar rats. The possible existence of slight differences in the
age of ovarian maturation among different rat strains can-
not be ruled out.
In conclusion, the presence of aberrant ovulations in very
young GPIR, closely resembling those in adult rats lacking
P and PG actions, strongly suggests that the capacity of the
immature ovary to undergo changes leading to effective
ovulation is not fully established in Wistar rats primed
with eCG before 25 days of age. This should be taken into
account when using the GPIR model for studies focused
on ovulation.
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